Cureus
Predictors of Successful Prandial Insulin Withdrawal Following the Initiation of Therapy Based on Glucagon-Like Peptide-1 (GLP-1) in Adults With Type 2 Diabetes (T2D): A Systematic Review of Clinical, Biochemical, and Treatment-Related Factors
By Lamyaa A Elhassan, Abdallah Adel Hassan Mohamed Abdelsalam, Mohamed Abdelrahman Mohamed Ali and 6 others.
Abstract
Glucagon-like peptide-1 (GLP-1)-based therapy may permit withdrawal of scheduled prandial insulin in adults with type 2 diabetes.The clinical and biochemical factors associated with successful withdrawal remain less clearly established than the feasibility of treatment simplification.PubMed, Embase, Scopus, and Web of Science were searched for publications from January 1, 2021 through September
Keywords
- Diabetes Treatment and Management
- glucagon-like peptide-1
- type 2 diabetes
- predictors of treatment success